Decompensated Chronic Heart Failure Reduces Plasma L-carnitine

Area of Science:

• Cardiology
• Biochemistry
• Metabolic Medicine

Background:

• The heart relies on aerobic metabolism, utilizing fatty acids as its primary energy source.
• L-carnitine is crucial for transporting fatty acids into mitochondria for energy production.
• Metabolic alterations in decompensated chronic heart failure can disrupt L-carnitine metabolism and cardiac energy supply.

Purpose of the Study:

• To investigate plasma L-carnitine levels in patients experiencing chronic heart failure decompensation.
• To assess the relationship between L-carnitine status and cardiac decompensation.

Main Methods:

• A cross-sectional study involving 109 chronic heart failure patients.
• Participants were categorized into compensated and decompensated heart failure groups.
• Plasma L-carnitine was quantified using a spectrophotometric enzymatic assay.

Main Results:

• Significantly lower plasma L-carnitine concentrations were observed in the decompensated heart failure group (p < 0.0001).
• Approximately 29.1% of decompensated heart failure patients had L-carnitine levels below the established reference range (<20 µmol/L).

Conclusions:

• Reduced plasma L-carnitine is associated with decompensated chronic systolic heart failure.
• Plasma L-carnitine assessment could be a valuable tool in managing patients with cardiac decompensation.